Influenza vaccination with PREFLUCEL: vaccination motivation and tolarability

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003253

Enrollment

1200

Registered

2011-09-07

Start date

2011-09-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza prophylaxis in adults and older persons J11.1

Interventions

Group 1: At Baseline, the basic data of patients vaccinated with PREFLUCEL is documented in the CRF once (demographics, concomitant diseases, data on previous influenza vaccinations, the patients moti

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have been vaccinated with PREFLUCEL for influenza prophylaxis and who signed a written informed consent to participate in this non-interventional study.

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
Identify methods for motivating patients for influenza vaccination in practices: once per site on a separate questionnaire. Collect patients' motivation and indication for influenza vaccination: once in the CRF. Document the tolerability of the PREFLUCEL vaccination after about 4 weeks in the CRF.	—

Countries

Germany

Contacts

Public ContactAnja Reichert

Baxter Deutschland GmbH

anja_reichert at baxter.comTel.: 089 31701- 448

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026